Ken Griffin Sonoma Pharmaceuticals, Inc. Call Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SNOA
# of Institutions
19Shares Held
435KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA86.6KShares$303,2540.0% of portfolio
-
Jane Street Group, LLC New York, NY45.3KShares$158,5320.0% of portfolio
-
State Street Corp Boston, MA24.3KShares$85,1020.0% of portfolio
-
Hrt Financial LP New York, NY21.5KShares$75,3160.0% of portfolio
-
Xtx Topco LTD London, X019.8KShares$69,4190.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $10.9M
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...